Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults.
Increased risk of low bone mineral density in patients with non-alcoholic fatty liver disease: a cohort study.
Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity.
The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.
auses of mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol related Fatty Liver Disease (AFLD).
Fibroblast growth factor signalling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease
Longitudinal Association of Non-Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study.
Professor Christopher Byrne trained as a clinical scientist in the UK and the US, at Cardiff, Cambridge and Stanford Universities. He undertook a PhD studying liver lipid metabolism at Cambridge University. He was a post-doctoral fellow at Stanford University and then an MRC fellow at Cambridge University. He was appointed to the Chair of Endocrinology & Metabolism at the University of Southampton in 1999 and was inaugural Director of the Welcome Trust Clinical Research Facility at Southampton until 2004. He is currently Principal Investigator within the NIHR Southampton Biomedical Research Centre and is Consultant Metabolic Physician at University Hospitals Southampton. He has published ~300 publications related to metabolic syndrome and NAFLD and he was a former recipient of the Dorothy Hodgkin prize awarded by Diabetes UK for international research excellence related to diabetes.